Barclays
LNAI

Barclays’s Lunai Bioworks LNAI Stock Holding History

Barclays’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Hold
0
– -$1 – 5691
2025
Q2 		– Sell
-1,498
Closed -$41.8K – 5201
2025
Q1 		$65.1K Sell
1,498
-750
-33% -$48K ﹤0.01% 4543
2024
Q4 		$150K Buy
2,248
+1,379
+159% +$91.5K ﹤0.01% 4431
2024
Q3 		$33.6K Buy
869
+660
+316% +$45.8K ﹤0.01% 4821
2024
Q2 		$29.3K Buy
+209
New +$28.5K ﹤0.01% 4365
2023
Q2 		– Sell
-123
Closed -$8.99K – 4996
2023
Q1 		$8.99K Buy
123
+57
+86% +$5.02K ﹤0.01% 4763
2022
Q4 		$5.47K Buy
66
+56
+560% +$7.52K ﹤0.01% 4990
2022
Q3 		$2K Sell
10
-2
-17% -$365 ﹤0.01% 4640
2022
Q2 		$2K Buy
+12
New +$5.49K ﹤0.01% 4890
2021
Q3 		– Sell
-49
Closed -$20K – 4956
2021
Q2 		$20K Sell
49
-207
-81% -$67.5K ﹤0.01% 4497
2021
Q1 		$72K Buy
256
+88
+52% +$25.9K ﹤0.01% 4116
2020
Q4 		$39K Buy
168
+89
+113% +$22.5K ﹤0.01% 4517
2020
Q3 		$23K Sell
79
-17
-18% -$5.36K ﹤0.01% 4873
2020
Q2 		$33K Buy
96
+39
+68% +$11.8K ﹤0.01% 5074
2020
Q1 		$14K Sell
57
-115
-67% -$34.2K ﹤0.01% 5735
2019
Q4 		$69K Buy
172
+147
+588% +$64.6K ﹤0.01% 5637
2019
Q3 		$11K Sell
25
-7
-22% -$2.68K ﹤0.01% 6340
2019
Q2 		$12K Buy
32
+17
+113% +$8.29K ﹤0.01% 6523
2019
Q1 		$8K Buy
+15
New +$8.77K ﹤0.01% 6619

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays's LNAI Position: Q3 2025 in Review

Barclays held its Lunai Bioworks (LNAI) position steady in Q3 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5691.

Barclays first reported a position in LNAI in Q1 2019 and has held it in 18 quarters since. The position peaked at $150K in Q4 2024. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • Barclays held 0 shares of Lunai Bioworks worth $0 as of Q3 2025.
  • Barclays left its Lunai Bioworks share count unchanged in Q3 2025.
  • Lunai Bioworks made up ﹤0.01% of Barclays's portfolio in Q3 2025, its #5691 holding.
  • Barclays first reported a position in Lunai Bioworks in Q1 2019 and has held it in 18 quarters since.
  • Barclays's Lunai Bioworks position peaked at $150K in Q4 2024.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.